EDGAR Filing Documents for 0001144204-13-069524

Form 8-K - Current report:

SEC Accession No. 0001144204-13-069524

Filing Date

2013-12-30

Accepted

2013-12-30 16:35:52

Documents

Period of Report

2013-12-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v364174_8k.htm	8-K	26768
2	EXHIBIT 99.1	v364174_ex99-1.htm	EX-99.1	11456
3	GRAPHIC	image_01.jpg	GRAPHIC	7342
	Complete submission text file	0001144204-13-069524.txt		49896

Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067

Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709

ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)